COX-2 Inhibitor (NSAID)
Pregnancy: C (first/second trimester) — D (third trimester)
Celecoxib
Brand names: Celebrex
Adult dose
Dose: 100–200mg twice daily
Route: Oral
Frequency: Twice daily with food
OA: 200mg OD. RA: 100–200mg BD. Familial adenomatous polyposis: 400mg BD (adjunctive). Max 400mg/day.
Clinical pearls
- GI advantages over non-selective NSAIDs (CLASS trial) but NOT in those on aspirin
- Cardiovascular risk similar to other NSAIDs — AVOID in established CVD
- Sulfonamide structural component — allergy history to sulfonamides relevant
- Useful in patients with high GI bleed risk who need NSAID therapy
- Does not affect platelet aggregation — does not replace aspirin for CV protection
Contraindications
- Established ischaemic heart disease
- Cerebrovascular disease
- Peripheral arterial disease
- Sulfonamide allergy (cross-reactivity)
- Active PUD
- Severe hepatic impairment
Side effects
- Hypertension
- Fluid retention
- Oedema
- GI upset (less than non-selective NSAIDs)
- Hepatotoxicity
Interactions
- Warfarin — increased INR
- ACE inhibitors — blunted antihypertensive effect
- Lithium — increased levels
- Fluconazole — increases celecoxib levels
Monitoring
- Blood pressure
- Renal function (prolonged use)
- LFTs
- Cardiovascular symptoms
Reference: CLASS trial; EMA NSAID Safety Review; BNF. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
- BALL Score for Relapsed/Refractory CLL · Leukaemia
Pathways
- Hip Fracture Pathway · NICE CG124; BPT
- Cauda Equina Syndrome · Society of British Neurological Surgeons; BOA — Best Practice
- Knee Soft Tissue Injury (ACL / MCL / Meniscus) · BOA; Royal College of Surgeons
- Shoulder Dislocation · BOA; RCEM
- Scaphoid Fracture · BOA; BSSH
- Pelvic Fracture · BOA; ATLS; NICE NG39